Sensorimotor Training for Chronic Low Back Pain, Risk of Cardiovascular Events Following Gout Flares, Dialysis Facility Ownership and Patient Outcomes, and more
Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the August 2, 2022, issue. (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - August 2, 2022 Category: General Medicine Authors: JAMA Network Source Type: podcasts
FDA adds Boxed Warning for increased risk of death with gout medicine Uloric (febuxostat)
(Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - December 21, 2019 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
FDA Drug Safety Podcast: FDA to evaluate increased risk of heart-related death and death from all causes with the gout medicine febuxostat (Uloric)
(Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - July 12, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: podcasts
FDA adds Boxed Warning for increased risk of death with gout medicine Uloric (febuxostat)
(Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - June 20, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: podcasts
FDA Drug Safety Podcast: FDA to evaluate increased risk of heart-related death and death from all causes with the gout medicine febuxostat (Uloric)
(Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - June 20, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: podcasts
FDA adds Boxed Warning for increased risk of death with gout medicine Uloric (febuxostat)
(Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - March 5, 2019 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
FDA Drug Safety Podcast: FDA adds Boxed Warning for increased risk of death with gout medicine Uloric (febuxostat)
On February 21, 2019 FDA concluded there is an increased risk of death with Uloric (active ingredient febuxostat) compared to another gout medicine, allopurinol. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - February 27, 2019 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
FDA Drug Safety Podcast: FDA to evaluate increased risk of heart-related death and death from all causes with the gout medicine febuxostat (Uloric)
On November 15, 2017, FDA alerted the public that preliminary results from a safety clinical trial show an increased risk of heart-related death with febuxostat (brand name Uloric) compared to another gout medicine called allopurinol. We required the Uloric drug manufacturer, Takeda Pharmaceuticals, to conduct this safety study when we approved the medicine in 2009. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - November 20, 2017 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
PodMed – Week of May 15, 2107
This week’s topics include cancer mutations in endometriosis, adverse events with novel agents approved by the FDA, a diet for gout, and the utility of the NHLBI database. Program notes: 0:32 Cancer mutations in endometrial tissue 1:30 Less than 1% becomes malignant 2:30 Maybe takes multiple mutations 3:30 Very anxiety producing 4:00 Database of the […] (Source: Johns Hopkins Medicine Weekly Health News)
Source: Johns Hopkins Medicine Weekly Health News - May 12, 2017 Category: Consumer Health News Authors: Elizabeth Tracey Johns Hopkins Medicine Tags: All Podcasts Cancer Diet Genetics Heart And Vascular PodMed Research Source Type: podcasts
Morning Report: Sleep Apnea, Cervical Cancer, CV Risk in Gout
Dr Arefa Cassoobhoy highlights some of this week ' s most important medical news: the new USPSTF statement on sleep apnea screening, underestimated cervical cancer mortality, and cardiovascular risk in gout. (Source: Medscape Medscape Podcast)
Source: Medscape Medscape Podcast - February 3, 2017 Category: Journals (General) Authors: Medscape Source Type: podcasts
Arefa MD's Morning Report: Angina; DASH for Gout; Meds After a Fall
Dr Arefa Cassoobhoy provides a quick rundown of this week ' s news on recognition of angina, use of the DASH diet to reduce serum uric acid, and fracture-promoting drug use after a fragility fracture. (Source: Medscape Medscape Podcast)
Source: Medscape Medscape Podcast - September 2, 2016 Category: Journals (General) Authors: Medscape Source Type: podcasts
Hot Joints
Mr Mike Rafferty does an overview of the three main conditions that cause hot joints - gout, pseudogout and septic arthritis. (Source: Podmedics - Medical Podcasts)
Source: Podmedics - Medical Podcasts - October 30, 2014 Category: Journals (General) Authors: Podmedics Source Type: podcasts
